What is the current Price Target for the PureTech Health Plc - ADR stock?

The average PureTech Health Plc - ADR target price is $6.96. This is -59.42% lower than the current stock price. The highest price target is -58.23%, the lowest is -59.82%. 3 Analysts have issued a price target PureTech Health Plc - ADR 2026 .

How high will the PureTech Health Plc - ADR stock rise?

No reliable answer can be given as to how high the PureTech Health Plc - ADR stock will rise. The performance of stocks, including the PureTech Health Plc - ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the PureTech Health Plc - ADR stock today?

The performance of PureTech Health Plc - ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the PureTech Health Plc - ADR stock fall?

The decline in PureTech Health Plc - ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

PureTech Health Plc - ADR Forecast, price target & analysts

$17.15

0.58% yesterday

Nasdaq, Aug 11, 10:00 pm CET

ISIN

GB00BY2Z0H74

Symbol

PRTC

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

PureTech Health Plc - ADR Target price 2025 - Analyst rating & recommendation

PureTech Health Plc - ADR Classifications & Recommendation:

Buy

80%

Hold

20%

PureTech Health Plc - ADR Price Target

Target Price	$6.96
Price	$17.15
Deviation	59.42% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target PureTech Health Plc - ADR 2026 . The average PureTech Health Plc - ADR target price is $6.96. This is 59.42% register free of charge lower than the current stock price. The highest price target is $7.16 58.23% register free of charge , the lowest is $6.89 59.82% register free of charge .
	A rating was issued by 5 analysts: 4 Analysts recommend PureTech Health Plc - ADR to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the PureTech Health Plc - ADR stock has an average upside potential 2026 of 59.42% register free of charge . Most analysts recommend the PureTech Health Plc - ADR stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	0.21	-0.59
	187.50%	380.95%
P/E		negative

3 Analysts have issued a PureTech Health Plc - ADR forecast for earnings per share. The average PureTech Health Plc - ADR EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$0.21	187.50%
2025	$-0.59 380.95% Unlock
2026	$-0.65 10.17% Unlock
2027	$-0.71 9.23% Unlock

Current	71.46	200.41%
2025	-29.03 140.63% Unlock
2026	-26.33 9.30% Unlock
2027	-24.26 7.86% Unlock

PureTech Health Plc - ADR...

Current PureTech Health Plc - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Jefferies	Locked ➜ Locked	Locked	Dec 16 2024

Analyst Rating	Date
Locked Jefferies: Locked ➜ Locked	Dec 16 2024

Discover more stocks with a high price target

Deutsche Telekom 29.37%

BioNTech SE - ADR 28.36%

Alibaba Group Holding Ltd 27.69%

PayPal 25.45%

Walt Disney 22.35%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now